The anxiodepressive comorbidity in chronic pain

Current Opinion in Anaesthesiology

Volumn 27, Issue 5, 2014, Pages 520-527

  Yalcin, Ipek ^a,b   Barrot, Michel ^a,b  

^a Institut des Neurosciences Cellulaires et Intégratives UPR3212   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Anxiety; Depression; Mood disorders; Pain

Indexed keywords

ANXIETY DISORDER; CHRONIC PAIN; COMORBIDITY; DEPRESSION; FIBROMYALGIA; HUMAN; INFLAMMATORY PAIN; MENTAL DISEASE; MOOD DISORDER; NEUROIMAGING; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANXIETY DISORDERS; DEPRESSIVE DISORDER; PREVALENCE;

ANXIETY DISORDERS; CHRONIC PAIN; COMORBIDITY; DEPRESSIVE DISORDER; HUMANS; PREVALENCE;

EID: 84925756747     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0000000000000116     Document Type: Review

References (128)

1. Breivik H, Collett B, Ventafridda V., et al. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2006; 10:287-333.
2. Elliott AM, Smith BH, Penny K.I., et al. The epidemiology of chronic pain in the community. Lancet 1999; 354:1248-1252.
3. Haanpaa M, Attal N, Backonja M., et al. NeuPSIG guidelines on neuropathic pain assessment. Pain 2011; 152:14-27.
4. Attal N, Lanteri-Minet M, Laurent B., et al. The specific disease burden of neuropathic pain: results of a French nationwide survey. Pain 2011; 152:2836-2843.
5. Bair MJ, Robinson RL, Katon W, et al. Depression and pain comorbidity: a literature review. Arch Intern Med 2003; 163:2433-2445.
6. Maletic V, Raison CL. Neurobiology of depression, fibromyalgia and neuropathic pain. Front Biosci 2009; 14:5291-5338.
7. Fietta P, Manganelli P. Fibromyalgia and psychiatric disorders. Acta Biomed 2007; 78:88-95.
8. Blackburn-Munro G, Blackburn-Munro RE. Chronic pain, chronic stress and depression: coincidence or consequence? J Neuroendocrinol 2001; 13:1009-1023.
9. Attal N, Masselin-Dubois A, Martinez V., et al. Does cognitive functioning predict chronic pain? Results from a prospective surgical cohort. Brain 2014; 137:904-917.
10. Baliki MN, Petre B, Torbey S., et al. Corticostriatal functional connectivity predicts transition to chronic back pain. Nat Neurosci 2012; 15:1117-1119.
11. Barrot M. Tests and models of nociception and pain in rodents. Neuroscience 2012; 211:39-50.
12. Colleoni M, Sacerdote P. Murine models of human neuropathic pain. Biochim Biophys Acta 2010; 1802:924-933.
13. Jaggi AS, Jain V, Singh N. Animal models of neuropathic pain. Fundam Clin Pharmacol 2011; 25:1-28.
14. Sorkin LS, Yaksh TL. Behavioral models of pain states evoked by physical injury to the peripheral nerve. Neurotherapeutics 2009; 6:609-619.
15. Alba-Delgado C, Llorca-Torralba M, Horrillo I., et al. Chronic pain leads to concomitant noradrenergic impairment and mood disorders. Biol Psychiatry 2013; 73:54-62.
16. Goncalves L, Silva R, Pinto-Ribeiro F, et al. Neuropathic pain is associated with depressive behaviour and induces neuroplasticity in the amygdala of the rat. Exp Neurol 2008; 213:48-56.
17. Suzuki T, Amata M, Sakaue G., et al. Experimental neuropathy in mice is associated with delayed behavioral changes related to anxiety and depression. Anesth Analg 2007; 104:1570-1577;.
18. Yalcin I, Bohren Y, Waltisperger E., et al. A time-dependent history of mood disorders in a murine model of neuropathic pain. Biol Psychiatry 2011; 70:946-953
19. Roeska K, Ceci A, Treede RD, et al. Effect of high trait anxiety on mechanical hypersensitivity in male rats. Neurosci Lett 2009; 464:160-164.
20. Benbouzid M, Pallage V, Rajalu M., et al. Sciatic nerve cuffing in mice: a model of sustained neuropathic pain. Eur J Pain 2008; 12:591-599.
21. Zeng Q, Wang S, Lim G., et al. Exacerbated mechanical allodynia in rats with depression-like behavior. Brain Res 2008; 1200:27-38.
22. Hu Y, Yang J, Wang Y., et al. Amitriptyline rather than lornoxicam ameliorates neuropathic pain-induced deficits in abilities of spatial learning and memory. Eur J Anaesthesiol 2010; 27:162-168.
23. Huang W, Calvo M, Karu K., et al. A clinically relevant rodent model of the HIV antiretroviral drug stavudine induced painful peripheral neuropathy. Pain 2013; 154:560-575.
24. Wallace VC, Blackbeard J, Pheby T., et al. Pharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy. Pain 2007; 133:47-63.
25. Wallace VC, Blackbeard J, Segerdahl A.R., et al. Characterization of rodent models of HIV-gp120 and antiretroviral-associated neuropathic pain. Brain 2007; 130:2688-2702.
26. Wallace VC, Segerdahl AR, Blackbeard J, et al. Anxiety-like behaviour is attenuated by gabapentin, morphine and diazepam in a rodent model of HIV antiretroviral-associated neuropathic pain. Neurosci Lett 2008; 448:153-156.
27. Hasnie FS, Breuer J, Parker S., et al. Further characterization of a rat model of varicella zoster virus-associated pain: relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs. Neuroscience 2007; 144:1495-1508.
28. Wang J, Goffer Y, Xu D., et al. A single subanesthetic dose of ketamine relieves depression-like behaviors induced by neuropathic pain in rats. Anesthesiology 2011; 115:812-821.
29. Andrews N, Legg E, Lisak D., et al. Spontaneous burrowing behaviour in the rat is reduced by peripheral nerve injury or inflammation associated pain. Eur J Pain 2012; 16:485-495.
30. Palermo TM, Wilson AC, Lewandowski A.S., et al. Behavioral and psychosocial factors associated with insomnia in adolescents with chronic pain. Pain 2011; 152:89-94.
31. Tang NK, Goodchild CE, Sanborn A.N., et al. Deciphering the temporal link between pain and sleep in a heterogeneous chronic pain patient sample: a multilevel daily process study. Sleep 2012; 35:675-687A.
32. Krystal AD. Psychiatric disorders and sleep. Neurol Clin 2012; 30:1389-1413.
33. Andersen ML, Tufik S. Sleep patterns over 21-day period in rats with chronic constriction of sciatic nerve. Brain Res 2003; 984:84-92.
34. Narita M, Niikura K, Nanjo-Niikura K, et al. Sleep disturbances in a neuropathic pain-like condition in the mouse are associated with altered GABAergic transmission in the cingulate cortex. Pain 2011; 152:1358-1372.
35. Takemura Y, Yamashita A, Horiuchi H., et al. Effects of gabapentin on brain hyperactivity related to pain and sleep disturbance under a neuropathic painlike state using fMRI and brain wave analysis. Synapse 2011; 65:668-676.
36. Dick BD, Rashiq S. Disruption of attention and working memory traces in individuals with chronic pain. Anesth Analg 2007; 104:1223-1229;.
37. Legrain V, Damme SV, Eccleston C, et al. A neurocognitive model of attention to pain: behavioral and neuroimaging evidence. Pain 2009; 144:230-232.
38. Cardoso-Cruz H, Lima D, Galhardo V. Impaired spatial memory performance in a rat model of neuropathic pain is associated with reduced hippocampus-prefrontal cortex connectivity. J Neurosci 2013; 33:2465-2480.
39. Ren WJ, Liu Y, Zhou L.J., et al. Peripheral nerve injury leads to working memory deficits and dysfunction of the hippocampus by upregulation of TNF-alpha in rodents. Neuropsychopharmacology 2011; 36:979-992.
40. Leite-Almeida H, Cerqueira JJ, Wei H, et al. Differential effects of left/right neuropathy on rats' anxiety and cognitive behavior. Pain 2012; 153:2218-2225.
41. Bomholt SF, Mikkelsen JD, Blackburn-Munro G. Normal hypothalamo-pitui-tary-adrenal axis function in a rat model of peripheral neuropathic pain. Brain Res 2005; 1044:216-226.
42. Ulrich-Lai YM, Xie W, Meij J.T., et al. Limbic and HPA axis function in an animal model of chronic neuropathic pain. Physiol Behav 2006; 88:67-76.
43. Kilburn-Watt E, Banati RB, Keay KA. Altered thyroid hormones and behavioural change in a sub-population of rats following chronic constriction injury. J Neuroendocrinol 2010; 22:960-970.
44. Obermann M, Rodriguez-Raecke R, Naegel S., et al. Gray matter volume reduction reflects chronic pain in trigeminal neuralgia. Neuroimage 2013; 74:352-358.
45. Peyron R, Laurent B, Garcia-Larrea L. Functional imaging of brain responses to pain. A review and meta-analysis (2000). Neurophysiol Clin 2000; 30:263-288.
46. Mutso AA, Radzicki D, Baliki M.N., et al. Abnormalities in hippocampal functioning with persistent pain. J Neurosci 2012; 32:5747-5756.
47. Zimmerman ME, Pan JW, Hetherington H.P., et al. Hippocampal correlates of pain in healthy elderly adults: a pilot study. Neurology 2009; 73:1567-1570.
48. Liu J, Hao Y, Du M., et al. Quantitative cerebral blood flow mapping and functional connectivity of postherpetic neuralgia pain: a perfusion fMRI study. Pain 2013; 154:110-118.
49. Drevets WC. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol 2001; 11:240-249.
50. Drevets WC, Ongur D, Price JL. Neuroimaging abnormalities in the sub-genual prefrontal cortex: implications for the pathophysiology of familial mood disorders. Mol Psychiatry 1998; 3:220-226; 190-221.
51. Vartiainen N, Kallio-Laine K, Hlushchuk Y., et al. Changes in brain function and morphology in patients with recurring herpes simplex virus infections and chronic pain. Pain 2009; 144:200-208.
52. Li XY, Ko HG, Chen T, et al. Alleviating neuropathic pain hypersensitivity by inhibiting PKMzeta in the anterior cingulate cortex. Science 2010; 330:1400-1404.
53. Ning L, Ma LQ, Wang Z.R., et al. Chronic constriction injury induced long-term changes in spontaneous membrane-potential oscillations in anterior cingulate cortical neurons in vivo. Pain Physician 2013; 16:E577-589.
54. Paulson PE, Casey KL, Morrow TJ. Long-term changes in behavior and regional cerebral blood flow associated with painful peripheral mononeuro-pathy in the rat. Pain 2002; 95:31-40.
55. Seminowicz DA, Laferriere AL, Millecamps M, et al. MRI structural brain changes associated with sensory and emotional function in a rat model of long-term neuropathic pain. Neuroimage 2009; 47:1007-1014.
56. Qu C, King T, Okun A., et al. Lesion of the rostral anterior cingulate cortex eliminates the aversiveness of spontaneous neuropathic pain following partial or complete axotomy. Pain 2011; 152:1641-1648.
57. Toyoda H, Zhao MG, Zhuo M. Enhanced quantal release of excitatory transmitter in anterior cingulate cortex of adult mice with chronic pain. Mol Pain 2009; 5:4.
58. Xu H, Wu LJ, Wang H, et al. Presynaptic and postsynaptic amplifications of neuropathic pain in the anterior cingulate cortex. J Neurosci 2008; 28:7445-7453.
59. Blom SM, Pfister JP, Santello M, et al. Nerve injury-induced neuropathic pain causes disinhibition of the anterior cingulate cortex. J Neurosci 2014; 34:5754-5764
60. Terada M, Kuzumaki N, Hareyama N, et al. Suppression of enriched environment-induced neurogenesis in a rodent model of neuropathic pain. Neurosci Lett 2008; 440:314-318.
61. Veinante P, Yalcin I, Barrot M. The amygdala between sensation and affect: a role in pain. J Mol Psychiatry 2013; 1:14.
62. Ikeda R, Takahashi Y, Inoue K., et al. NMDA receptor-independent synaptic plasticity in the central amygdala in the rat model of neuropathic pain. Pain 2007; 127:161-172.
63. Ansah OB, Bourbia N, Goncalves L., et al. Influence of amygdaloid glutama-tergic receptors on sensory and emotional pain-related behavior in the neuropathic rat. Behav Brain Res 2010; 209:174-178.
64. Goncalves L, Dickenson AH. Asymmetric time-dependent activation of right central amygdala neurones in rats with peripheral neuropathy and pregabalin modulation. Eur J Neurosci 2012; 36:3204-3213.
65. Pedersen LH, Scheel-Kruger J, Blackburn-Munro G. Amygdala GABA-A receptor involvement in mediating sensory-discriminative and affective-motivational pain responses in a rat model of peripheral nerve injury. Pain 2007; 127:17-26.
66. Rouwette T, Vanelderen P, de Reus M, et al. Experimental neuropathy increases limbic forebrain CRF. Eur J Pain 2012; 16:61-71.
67. Narita M, Kaneko C, Miyoshi K., et al. Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala. Neuropsycho-pharmacology 2006; 31:739-750.
68. Bravo L, Torres-Sanchez S, Alba-Delgado C, et al. Pain exacerbates chronic mild stress-induced changes in noradrenergic transmission in rats. Eur Neuropsychopharmacol 2014; 24:996-1003.
69. Becerra L, Breiter HC, Wise R, et al. Reward circuitry activation by noxious thermal stimuli. Neuron 2001; 32:927-946.
70. Chang PC, Pollema-Mays SL, Centeno M.V., et al. Role of nucleus accumbens in neuropathic pain: linked multiscale evidence in the rat transitioning to neuropathic pain. Pain 2014; 155:1128-1139.
71. Goffer Y, Xu D, Eberle S.E., et al. Calcium-permeable AMPA receptors in the nucleus accumbens regulate depression-like behaviors in the chronic neuropathic pain state. J Neurosci 2013; 33:19034-19044.
72. Vialou V, Robison AJ, Laplant Q.C., et al. DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses. Nat Neurosci 2010; 13:745-752.
73. Jimenez-Rodriguez I, Garcia-Leiva JM, Jimenez-Rodriguez BM, et al. Suicidal ideation and the risk of suicide in patients with fibromyalgia: a comparison with nonpain controls and patients suffering from low-back pain. Neuropsy-chiatr Dis Treat 2014; 10:625-630.
74. Trinanes Y, Gonzalez-Villar A, Gomez-Perretta C, et al. Suicidality in chronic pain: predictors of suicidal ideation in fibromyalgia. Pain Pract 2014. [Epub ahead of print]
75. Arnold LM, Hudson JI, Keck P.E., et al. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry 2006; 67:1219-1225.
76. Thieme K, Turk DC, Flor H. Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables. Psychosom Med 2004; 66:837-844.
77. Benjamin S, Morris S, McBeth J., et al. The association between chronic widespread pain and mental disorder: a population-based study. Arthritis Rheum 2000; 43:561-567.
78. Dreyer L, Kendall S, Danneskiold-Samsoe B, et al. Mortality in a cohort of Danish patients with fibromyalgia: increased frequency of suicide. Arthritis Rheum 2010; 62:3101-3108.
79. Wolfe F, Hassett AL, Walitt B, et al. Mortality in fibromyalgia: a study of 8, 186 patients over thirty-five years. Arthritis Care Res (Hoboken) 2011; 63:94-101.
80. Calandre EP, Vilchez JS, Molina-Barea R, et al. Suicide attempts and risk of suicide in patients with fibromyalgia: a survey in Spanish patients. Rheumatology (Oxford) 2011; 50:1889-1893.
81. Lee YH, Choi SJ, Ji J.D., et al. Candidate gene studies of fibromyalgia: a systematic review and meta-analysis. Rheumatol Int 2012; 32:417-426.
82. Martinez-Jauand M, Sitges C, Rodriguez V., et al. Pain sensitivity in fibro-myalgia is associated with catechol-O-methyltransferase (COMT) gene. Eur J Pain 2013; 17:16-27.
83. Barbosa FR, Matsuda JB, Mazucato M, et al. Influence of catechol-O-methyltransferase (COMT) gene polymorphisms in pain sensibility of Brazilian fibromialgia patients. Rheumatol Int 2012; 32:427-430.
84. Gursoy S, Erdal E, Sezgin M., et al. Which genotype of MAO gene that the patients have are likely to be most susceptible to the symptoms of fibro-myalgia? Rheumatol Int 2008; 28:307-311.
85. Cohen H, Buskila D, Neumann L., et al. Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5-HTTLPR) polymorphism, and relationship to anxiety-related personality traits. Arthritis Rheum 2002; 46:845-847.
86. Vargas-Alarcon G, Fragoso JM, Cruz-Robles D, et al. Association of adre-nergic receptor gene polymorphisms with different fibromyalgia syndrome domains. Arthritis Rheum 2009; 60:2169-2173.
87. Kashikar-Zuck S, Cunningham N, Sil S., et al. Long-term outcomes of adolescents with juvenile-onset fibromyalgia in early adulthood. Pediatrics 2014; 133:e592-600.
88. Cagnie B, Coppieters I, Denecker S., et al. Central sensitization in fibromyalgia? A systematic review on structural and functional brain MRI. Semin Arthritis Rheum 2014. [Epub ahead of print]
89. Robinson ME, Craggs JG, Price DD, et al. Gray matter volumes of pain-related brain areas are decreased in fibromyalgia syndrome. J Pain 2011; 12:436-443.
90. Wood PB, Glabus MF, Simpson R, et al. Changes in gray matter density in fibromyalgia: correlation with dopamine metabolism. J Pain 2009; 10:609-618.
91. Jensen KB, Loitoile R, Kosek E., et al. Patients with fibromyalgia display less functional connectivity in the brain's pain inhibitory network. Mol Pain 2012; 8:32.
92. Cifre I, Sitges C, Fraiman D., et al. Disrupted functional connectivity of the pain network in fibromyalgia. Psychosom Med 2012; 74:55-62.
93. Gracely RH, Petzke F, Wolf J.M., et al. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002; 46:1333-1343.
94. Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 2000; 25:1-35.
95. Raison CL, Miller AH. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry 2003; 160:1554-1565.
96. Macedo JA, Hesse J, Turner J.D., et al. Glucocorticoid sensitivity in fibromyal-gia patients: decreased expression of corticosteroid receptors and gluco-corticoid-induced leucine zipper. Psychoneuroendocrinology 2008; 33:799-809.
97. Russell IJ, Vaeroy H, Javors M., et al. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992; 35:550-556.
98. Wood PB. Role of central dopamine in pain and analgesia. Expert Rev Neurother 2008; 8:781-797.
99. Fitzgerald CT, Carter LP. Possible role for glutamic acid decarboxylase in fibromyalgia symptoms: a conceptual model for chronic pain. Med Hypotheses 2011; 77:409-415.
100. Calandre EP, Slim M, Garcia-Leiva JM, et al. Agomelatine for the treatment of patients with fibromyalgia and depressive symptomatology: an uncontrolled, 12-week, pilot study. Pharmacopsychiatry 2014; 47:67-72.
101. Senel K, Baygutalp F, Baykal T., et al. Melatonin levels in premenopausal women with fibromyalgia syndrome. Rheumatol Int 2013; 33:1609-1610.
102. Kehl LJ, Trempe TM, Hargreaves KM. A new animal model for assessing mechanisms and management of muscle hyperalgesia. Pain 2000; 85:333-343.
103. Sluka KA, Kalra A, Moore SA. Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia. Muscle Nerve 2001; 24:37-46.
104. Schafers M, Sorkin LS, Sommer C. Intramuscular injection of tumor necrosis factor-alpha induces muscle hyperalgesia in rats. Pain 2003; 104:579-588.
105. Suarez-Roca H, Quintero L, Arcaya J.L., et al. Stress-induced muscle and cutaneous hyperalgesia: differential effect of milnacipran. Physiol Behav 2006; 88:82-87.
106. Liu YT, Shao YW, Yen C.T., et al. Acid-induced hyperalgesia and anxio-depressive comorbidity in rats. Physiol Behav 2014; 131C:105-110.
107. Nagakura Y, Oe T, Aoki T., et al. Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: a putative animal model of fibromyalgia. Pain 2009; 146:26-33.
108. Nishiyori M, Uchida H, Nagai J., et al. Permanent relief from intermittent cold stress-induced fibromyalgia-like abnormal pain by repeated intrathecal administration of antidepressants. Mol Pain 2011; 7:69.
109. Sheehy C, Murphy E, Barry M. Depression in rheumatoid arthritis-underscoring the problem. Rheumatology (Oxford) 2006; 45:1325-1327.
110. Ho RC, Fu EH, Chua A.N., et al. Clinical and psychosocial factors associated with depression and anxiety in Singaporean patients with rheumatoid arthritis. Int J Rheum Dis 2011; 14:37-47.
111. Goodhand JR, Wahed M, Mawdsley J.E., et al. Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors. Inflamm Bowel Dis 2012; 18:2301-2309.
112. Covic T, Cumming SR, Pallant J.F., et al. Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the hospital, Anxiety and Depression Scale (HADS). BMC Psychiatry 2012; 12:6.
113. Amorim D, David-Pereira A, Pertovaara A., et al. Amitriptyline reverses hyperalgesia and improves associated mood-like disorders in a model of experimental monoarthritis. Behav Brain Res 2014; 265:12-21.
114. Kim H, Chen L, Lim G., et al. Brain indoleamine 2, 3-dioxygenase contributes to the comorbidity of pain and depression. J Clin Invest 2012; 122:2940-2954.
115. Parent AJ, Beaudet N, Beaudry H., et al. Increased anxiety-like behaviors in rats experiencing chronic inflammatory pain. Behav Brain Res 2012; 229:160-167.
116. Narita M, Kuzumaki N, Kaneko C., et al. Chronic pain-induced emotional dysfunction is associated with astrogliosis due to cortical delta-opioid receptor dysfunction. J Neurochem 2006; 97:1369-1378.
117. Borges G, Neto F, Mico J.A., et al. Reversal of monoarthritis-induced affective disorders by diclofenac in rats. Anesthesiology 2014; 120:1476-1490.
118. Chen J, Song Y, Yang J., et al. The contribution of TNF-alpha in the amygdala to anxiety in mice with persistent inflammatory pain. Neurosci Lett 2013; 541:275-280.
119. Liu Y, Ho RC, Mak A. The role of interleukin (IL)-17 in anxiety and depression of patients with rheumatoid arthritis. Int J Rheum Dis 2012; 15:183-187.
120. Seminowicz DA, Labus JS, Bueller J.A., et al. Regional gray matter density changes in brains of patients with irritable bowel syndrome. Gastroenterology 2010; 139:48-57;.
121. Wartolowska K, Hough MG, Jenkinson M, et al. Structural changes of the brain in rheumatoid arthritis. Arthritis Rheum 2012; 64:371-379.
122. Gao YJ, Ren WH, Zhang Y.Q., et al. Contributions of the anterior cingulate cortex and amygdala to pain- and fear-conditioned place avoidance in rats. Pain 2004; 110:343-353.
123. Tanimoto S, Nakagawa T, Yamauchi Y., et al. Differential contributions of the basolateral and central nuclei of the amygdala in the negative affective component of chemical somatic and visceral pains in rats. Eur J Neurosci 2003; 18:2343-2350.
124. Deyama S, Takishita A, Tanimoto S., et al. Roles of beta- and alpha2-adrenoceptors within the central nucleus of the amygdala in the visceral pain-induced aversion in rats. J Pharmacol Sci 2010; 114:123-126.
125. Fu Y, Neugebauer V. Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior. J Neurosci 2008; 28:3861-3876.
126. Ji G, Fu Y, Ruppert K.A., et al. Pain-related anxiety-like behavior requires CRF1 receptors in the amygdala. Mol Pain 2007; 3:13.
127. Myers B, Greenwood-Van Meerveld B. Corticosteroid receptor-mediated mechanisms in the amygdala regulate anxiety and colonic sensitivity. Am J Physiol Gastrointest Liver Physiol 2007; 292:G1622-1629.
128. Gregoire S, Wattiez AS, Etienne M, et al. Monoarthritis-induced emotional and cognitive impairments in rats are sensitive to low systemic doses or intra-amygdala injections of morphine. Eur J Pharmacol 2014; 735C:1-9.